Full coverage: Multinationals

Income tax competition is the new corporation tax. And, as the state grows ever more reliant upon income tax, the companies paying the most of it want it to be reduced. What happens next?

Pascal Saint-Amans’s career as OECD tax director culminated one year ago when he secured a global agreement to overhaul corporation tax. As he leaves this position, he assesses the work remaining to be done.

In part two of our investigation into the Ingka Group's Irish corporate structures, we unlock the retail giant’s Irish-operated investment strategy and explain how a number of Irish subsidiaries in Ireland help reduce its overall tax liabilities.

From a discreet building in Ballsbridge, a few dozen staff running the Ingka Group's international bank and financial investment fund now manage over €30 billion in liquid assets – and counting. This investigation opens the door to the low-key Dublin office.

The Minister for Finance heads to an EU meeting in Prague hopeful of a 15% corporation tax directive, but the full OECD agreement is far from ready for implementation.

An international agreement has just led the Danish tax appeal body to reject a claim by the Irish subsidiary of a multinational that it didn’t have a permanent establishment in Denmark. There are many more with similar arrangements.

Cabot Financial Ireland and its Dublin subsidiaries have grown their assets and revenue from non-performing loans acquired from Portugal to Poland – as well as the taxable Irish profit arising from this business.

Instead of playing along the rules agreed by 137 countries to raise corporation tax to a global minimum, Democratic Senators have selected the bits that favour narrow American interests – and put international co-operation at risk.

For years, the Irish-headquartered medical supplier Covidien outsourced core functions to the US without paying Vat on transactions including preparations for its acquisition by Medtronic. The company’s successful tax appeal is now going down the legal route.

With over 200 staff, the Co Cork pharmaceutical factory was among those sold off by Pfizer in 2020 to combine with Mylan and form Viatris. New information is available on its first year of trading within the new group.